维生素中国E-新闻

Welcome to Vitamins China E-News!

China is the largest vitamin manufacturer and exporter in the world, playing a critical role in the global vitamin market.

Affected by the increasing demand of overseas market, China’s VC export volume rises by 12% year on year in Jan.-Aug. 2014. And VE increases by 20%.

As for the domestic market , the price of VC sees a downtrend because of the high inventory. Affected by the weak demand in Q4, the price of VC is expected to maintain low. In a whole, China's VA market riding high than that of last year, is mainly driven by the recovery of the downstream breeding industry. However, the market price of VA is to decline due to the increasing supply and stable demand. After Sept., the market price of VB2 booms thanks to the higher quotation made by the manufacturers led by Guangji Pharmaceutical.

In Oct., Garden Bio-chemical Stock went to public successfully, which is a matter of concern for the domestic vitamin industry. As the largest VD3 manufacturer in China, Garden Bio-chemical benefits from the price rise of VD3 and the higher gross profit margin.

The domestic vitamin industry seems going through merger and acquisition trend. Xinfu Pharmaceutical, the largest VB5 manufacturer in China, merges two subsidiaries for unified management and fast development. Changjiang Industry Investment Group gets the control of Guangji Pharmaceutical to a largest extent with long-term loans. Guanfu Household merges a VE intermediates manufacturer, Nengte Technology, which may have an effect on the competition pattern of domestic VE industry. Would all of these bring new opportunities and challenges to the vitamin industry at home and abroad? Let’s see!

RMB Exchange Rate: USD1=RMB6.1493; source: The People's Bank of China.